Chimeric antigen receptor (CAR) T cell therapy has transformed cancer treatment, but immune-related toxicities remain a significant challenge. Longitudinal single-cell analysis of whole blood offers an opportunity to characterize changes in immune cell populations and identify potential biomarkers associated with treatment-related neurotoxicity.
In this webinar, Evan Newell and Ivan Godinez will discuss how fixed whole blood samples can support longitudinal single-cell transcriptomic profiling of patients receiving CAR T cell therapy, revealing distinct neutrophil and monocyte populations associated with immune effector cell-associated neurotoxicity syndrome (ICANS), as well as approaches for integrating protein detection and simplifying sample collection.
Topics to be covered:
- Longitudinal single-cell RNA profiling of fixed whole blood
- Identification of immune cell signatures associated with neurotoxicity
- Tracking CAR T cell expansion and neutrophil phenotypes
- Integration of RNA and protein profiling in blood studies
Wednesday, December 9th 2026 | 11:00 AM – 12:30 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
![]() | Evan Newell, PhD |
![]() | Ivan Godinez, PhD |


.png)

